Christina Lake Cannabis (CLC) AI Stock Analysis

• Market Cap: $9.92M
• Dividend Yield: N/A
• Average Volume (3M): 24.25K
• Price to Earnings (P/E): 3.8
• Beta (1Y): -1.95
• Revenue Growth: 16.22%
• EPS Growth: -285.37%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 0.01
• Shares Outstanding: 248,093,570
• 10 Day Avg. Volume: 18,613
• 30 Day Avg. Volume: 24,245
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.24
• Enterprise Value/Revenue: 0.76
• Enterprise Value/Gross Profit: 1.34
• Enterprise Value/Ebitda: 5.86
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 51 Neutral
• Price Target: C$0.00 ▼(-100.00% Downside)

Christina Lake Cannabis has a mixed financial performance with revenue growth but declining profitability. The technical analysis indicates a bearish trend, while the valuation suggests the stock is undervalued. The absence of earnings call data and corporate events limits additional insights.

Christina Lake Cannabis Business Overview & Revenue Model

Company Description

Christina Lake Cannabis (CLC) is a Canadian licensed producer of cannabis, focusing on cultivating high-quality cannabis products for both the recreational and medical markets. The company operates in the rapidly growing cannabis sector, specializing in innovative cultivation techniques and sustainable practices. CLC offers a range of products, including dried flower, oils, and edibles, aimed at meeting diverse consumer preferences and regulatory standards.

How the Company Makes Money

Christina Lake Cannabis generates revenue primarily through the sale of its cannabis products to wholesalers, retailers, and directly to consumers. The company leverages its licensed production capabilities to cultivate and process cannabis, which is then sold in various forms, including dried flower, oils, and edibles. Key revenue streams include wholesale distribution agreements with provincial distributors and retail partnerships that allow CLC to expand its market reach. Additionally, the company may benefit from strategic partnerships with other cannabis businesses for co-branding or joint ventures, enhancing its product offerings and market presence. Factors contributing to its earnings include the increasing demand for cannabis products, effective marketing strategies, and compliance with regulatory requirements.

Christina Lake Cannabis Financial Statement Overview

Summary

Christina Lake Cannabis shows mixed financial performance. Revenue growth is positive, but profitability margins are under pressure. The balance sheet is stable with moderate leverage, but cash flow management needs improvement.

Income Statement

Christina Lake Cannabis shows a mixed performance in its income statement. The company has achieved a positive revenue growth rate of 6.89% in the TTM, indicating a growth trajectory. However, the gross profit margin has decreased significantly from 68.41% in 2024 to 34.22% in the TTM, reflecting increased cost pressures. The net profit margin remains low at 6.36%, suggesting limited profitability. The EBIT margin is negative, indicating operational challenges, although the EBITDA margin is positive, showing some operational efficiency.

Balance Sheet

The balance sheet of Christina Lake Cannabis reveals a moderate financial position. The debt-to-equity ratio is stable at 0.95, indicating a balanced leverage. The return on equity has improved to 10.65% in the TTM, showing better utilization of equity. However, the equity ratio is not explicitly provided, but the total assets and equity suggest a moderate equity base. The company should focus on maintaining its leverage and improving equity returns.

Cash Flow

The cash flow statement indicates a positive trend with a 12.92% growth in free cash flow in the TTM. The operating cash flow to net income ratio is low, suggesting that cash generation from operations is not fully aligned with net income. The free cash flow to net income ratio is negative, indicating potential cash flow challenges despite improvements. The company needs to enhance its cash flow management to support growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	16.15M	13.61M	11.78M	10.07M	3.63M	0.00
Gross Profit	9.13M	9.31M	3.61M	2.98M	56.72K	4.77M
EBITDA	2.09M	3.25M	-2.62M	-938.92K	-5.97M	-2.14M
Net Income	47.72K	865.00K	-4.13M	-1.74M	-6.78M	-5.32M
Balance Sheet
Total Assets	22.08M	23.37M	15.96M	18.79M	18.97M	17.80M
Cash, Cash Equivalents and Short-Term Investments	3.39M	1.85M	1.47M	1.84M	1.08M	1.84M
Total Debt	8.22M	10.27M	6.15M	6.45M	3.81M	4.06M
Total Liabilities	10.02M	12.57M	8.50M	7.66M	9.23M	8.35M
Stockholders Equity	12.06M	10.79M	7.46M	11.14M	9.74M	9.46M
Cash Flow
Free Cash Flow	6.66M	-4.13M	781.46K	394.55K	-5.85M	-8.10M
Operating Cash Flow	3.96M	221.02K	1.38M	1.18M	-4.62M	-3.32M
Investing Cash Flow	2.68M	-4.47M	-571.37K	-790.41K	-1.20M	-4.78M
Financing Cash Flow	-4.73M	4.59M	-1.15M	369.17K	5.06M	9.20M

Christina Lake Cannabis Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CLC, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 46.83 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CLC.

Christina Lake Cannabis Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MPH	―	C$11.38M	―	-7.15%	―	10.84%	48.57%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
CLC	―	$9.92M	3.85	-4.55%	―	16.22%	-285.37%
PWR	―	$7.31M	-41.67	116.45%	―	-100.00%	97.20%
RVV	―	C$6.28M	-1.56	-583.18%	―	―	-84.51%
AVNT	―	$6.96M	-0.31	-53.71%	―	26.36%	-8.21%
TRIP	―	$14.43M	-3.89	-19.44%	―	-8.27%	50.55%

Christina Lake Cannabis Corporate Events

Christina Lake Cannabis Secures Credit Facility and Lease Agreement

Christina Lake Cannabis Corp. has secured a $1.5 million revolving line of credit from a company director, Mervin Boychuk, with a two-year term and 15% interest, secured by a second mortgage on its property. Additionally, the company entered an 18-month equipment lease agreement with Boychuk, with an option to purchase the equipment post-lease, highlighting strategic financial maneuvers to bolster its operations.

Christina Lake Cannabis Extends Debenture Maturity Date

Christina Lake Cannabis announced an extension of the maturity date for its convertible debentures to September 7, 2026, while maintaining the interest rate. This amendment allows for quarterly repayments starting December 7, 2025, which could impact the company’s financial planning and stakeholder expectations positively.

Christina Lake Cannabis Proposes Amendments to Debenture Terms

Christina Lake Cannabis Corp. has announced its intention to amend the terms of its $960,000 convertible debentures issued in 2022, proposing to extend the maturity date by one year while keeping the interest rate unchanged. This strategic move aims to align debt obligations with operational cash flow cycles and recent expansion achievements, pending approval from debenture holders and the Canadian Securities Exchange.